{"name": "Sigma-Tau",
 "permalink": "sigma-tau",
 "crunchbase_url": "http://www.crunchbase.com/company/sigma-tau",
 "homepage_url": "http://www.sigmatau.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 21 12:33:26 UTC 2010",
 "updated_at": "Thu Jan 21 12:39:16 UTC 2010",
 "overview": "\u003Cp\u003ESigma-Tau is actively pursuing partnerships to commercially develop products that address the unmet medical needs of patients with rare diseases.\u003C/p\u003E\n\n\u003Cp\u003EThey offer their partners an experienced management team, core competencies in the global development and commercialization of products for rare diseases, and a strong financial position.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0007/4322/74322v1-max-150x150.jpg"],
     [[150,
       48],
      "assets/images/resized/0007/4322/74322v1-max-250x250.jpg"],
     [[150,
       48],
      "assets/images/resized/0007/4322/74322v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.dorbiopharma.com/news.aspx?titleId=351",
      "source_description": "Soligenix Announces Private Equity Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors",
      "raised_amount": 5160000.0,
      "raised_currency_code": "USD",
      "funded_year": 2010,
      "funded_month": 6,
      "funded_day": 16,
      "company":
       {"name": "Soligenix",
        "permalink": "soligenix",
        "image":
         {"available_sizes":
           [[[150,
              42],
             "assets/images/resized/0009/2621/92621v1-max-150x150.jpg"],
            [[250,
              70],
             "assets/images/resized/0009/2621/92621v1-max-250x250.jpg"],
            [[357,
              100],
             "assets/images/resized/0009/2621/92621v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 327000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.sigmatau.com/news/EnzonAgreement.asp",
    "source_description": "ENZON ANNOUNCES AGREEMENT TO SELL SPECIALTY PHARMACEUTICAL BUSINESS",
    "acquired_year": 2009,
    "acquired_month": 11,
    "acquired_day": 9,
    "company":
     {"name": "Enzon Pharmaceuticals",
      "permalink": "enzon-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[124,
            44],
           "assets/images/resized/0007/4321/74321v1-max-150x150.jpg"],
          [[124,
            44],
           "assets/images/resized/0007/4321/74321v1-max-250x250.jpg"],
          [[124,
            44],
           "assets/images/resized/0007/4321/74321v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}